Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-48329

Single-particle
3.2 Å
EMD-48329
3D View Gallery
Deposition: 17/12/2024
Map released: 30/07/2025
Last modified: 30/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48329
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9mkk summary report (pdf.gz) Map and 9mkk FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of arbekacin bound Escherichia coli 70S ribosome

EMD-48329

Single-particle
3.2 Å
EMD-48329
3D View Gallery
Deposition: 17/12/2024
Map released: 30/07/2025
Last modified: 30/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Escherichia coli
Sample: Escherichia coli 70S ribosome bound to tRNA-fMet, mRNA and arbekacin
Fitted models: 9mkk

Deposition Authors: Majumdar S, Parajuli NP, Ge X, Emmerich A, Sanyal S
Structure-function comparison of Arbekacin with other aminoglycosides elucidates its higher potency as bacterial translation inhibitor.
Majumdar S, Parajuli NP, Ge X, Sanyal S
(2025) Sci Rep , 15 , 18271 - 18271
PUBMED: 40415027
DOI: doi:10.1038/s41598-025-02391-3
ISSN: 2045-2322